Summary P-glycoprotein (PGP) is an energy-dependent efflux pump that serves to protect cells against the cytotoxicity of many natural product drugs including vinblastine (VBL). In this study we investigated the role of PGP in regulating initial VBL influx. The apparent influx of VBL, measured over the first 20 s, was 2-fold lower in KB-GRCI cells expressing a transfected mdrl gene at high level than in non-expressing parental KB-3-1 cells. Inhibition of PGP efflux function with dipyridamole increased the influx rate constant by 4.0-fold in the KB-GRC1 cells but only 2.1-fold in the KB-3-1 cells. Verapamil, another inhibitor of PGP-mediated efflux, increased the initial influx rate constant by 2.7-fold in the KB-GRCI cells but only 1.4-fold in the KB-3-1 cells. Inhibition of PGP function by depletion of ATP increased influx by 6.8-fold and 2.2-fold in the two cell types, respectively. Mutation of PGP at both ATP binding sites abolished its ability to limit initial influx. Thus, VBL is serving as an efficient substrate for the efflux pump even within the first few seconds of drug exposure, consistent with the hypothesis that PGP may directly efflux drug from the cell membrane.
Overexpression of the mdrl gene coding for the production of a 170 kd glycoprotein, PGP3, is often a prominent feature of the MDR phenotype (Endicott & Ling, 1989; Juranka et al., 1989) . Transfection of the mdrl gene into drug-sensitive clones confers drug resistance to cells that overexpress PGP (Debenham et al., 1986; Shen et al., 1986; Euda et al., 1987) .
The transmembrane location, energy dependence, correlation with resistance and extensive homology of the mdrl product with bacterial transport proteins is consistent with PGP acting as an energy-dependent efflux pump (Juranka et al., 1989; Beck, 1987; Gros et al., 1986; Chen et al., 1986) . A major strategy in reversing the MDR phenotype is to utilise agents that inhibit PGP function (Ford & Hait, 1990; Tsuruo et al., 1981) . For example, VPL's ability to inhibit drug efflux in many tumour types has been attributed to'its ability to bind to PGP (Cornwell et al., 1987; Safa, 1988; Naito & Tsuruo, 1989) , but the modulation is absent in MDR cell lines that do not overexpress the mdrl gene as their primary mechanism of resistance (Cole et al., 1989) .
There are a few reports indicating that mdrl overexpression may be associated with a change in drug influx (Ramu et al., 1989) , or may fail to alter efflux (Deffie et al., 1988) , and modulators of the MDR phenotype such as VPL do not inhibit drug efflux in every MDR cell line overexpressing mdrl . These data are difficult to interpret in light of the commonly accepted role of PGP as an efflux transporter. PGP shares extensive sequence homology with two major classes of transporters: (1) the multicomponent periplasmic protein-binding permeases that import substrates and (2) the hemolysin B-like proteins that export substrates (Juranka & Ling, 1989; Gross et al., 1986; Chen et al., 1987; Ames Ferro-Luzzi, 1986 ). The homology with proteins that transport substrates in and out of cells suggests that PGP is related to both types of transporters, and raises the question of whether PGP might have an influx function in addition to its efflux role (Riordan & Ling, 1985) .
We have observed that overexpression of PGP decreases the initial influx of VBL over the first 20 s employing drugCorrespondence: D.R. Shalinsky, Ligand Pharmaceuticals, 11149 N. Torrey Pines Rd., La Jolla, CA 92037, USA.
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sensitive KB-3-1 and MDR KB-GRCl cells*. KB-GRC1 cells theoretically differ from KB-3-1 cells only by expression of PGP following transfection of mdrl (Choi et al., 1988) , and are 67, 9.4, 4.5 and 1.5-fold cross-resistant to VBL, doxorubicin, colchicine and etoposide, respectively (ibid., Shalinsky et al., 1990a analysis according to the method of Thimmaiah and Sethi (1985) . [3H]-VBL was stable for at least 2 months when stored at -80°C. In addition, HPLC analysis of [3H]-VBL extracted from cellular homogenates indicated no decomposition under the experimental conditions employed in these studies. The final specific activity of the [3H]-VBL used for drug accumulation studies was 6.67 mCi j.mol-'.
Cell lines and culture medium The drug sensitive KB-3-1 line and its multidrug resistant subline, KB-GRCI, were obtained from Dr. Igor Roninson (University of Illinois, College of Medicine, Chicago, IL). The KB-GRCl line was derived by transfection of the wild-type mdrl gene coupled to a Moloney Murine Leukemia Virus long terminal repeat into KB-3-1 cells (Choi et al., 1988) . Routine culture of these cells has been previously described (Shalinsky et al., 1990b) .
Mouse L cell variants, KK, MM and NEO (Morse & Roninson, 1990) to subconfluent monolayer cultures in 60-mm dishes in 2 ml of culture medium equilibrated overnight in the CO2 incubator at 37°C as described (ibid.). At appropriate time points, the medium was aspirated and the cells were washed (3 x 5 ml) with ice cold PBS (Oxoid, Columbia, MD). Incubations were carried out in the CO2 incubator at 37°C for all time points ) 1 min. For time points A 1 min, incubations were carried out using medium pre-equilibrated in the CO2 incubator at 37°C. Time points were recorded from the addition of [3H]-VBL alone or with modulator to the first aspiration. The average time recorded from addition of 2 ml of radiolabelled medium to the dish until aspiration was 0.89 ± 0.25 s, and uptake experiments under the first min were highly reproducible with linear rate constants being obtained (ri>0.93). The cells were then digested overnight with 1 N NaOH, and neutralised aliquots were used for determination of protein content and cell associated radioactivity.
The percent of intracellular [3H]-VBL that was in a bound form during uptake was determined by exposing monolayer cells to [3H]-VBL for I h, washing the cells in PBS, resuspending in 1 ml of PBS and scraping with rubber policeman for transfer into 15 ml tubes. The cellular suspension was sonicated three times for 10 s on ice to destroy cellular membranes using a Vibra-cell (VC-50) sonicator (Sonics & Materials, Inc., Danbury, CT) set to 25 watts-/60 amplitudevibrations. An aliquot was removed, digested in 1 N NaOH, neutralised with equimolar HCI, and counted by liquid scintillation spectroscopy to determine total radioactivity. The rest of the sonicated suspension was filtered through CentrifeeR micropartition filters (Amicon, Beverly, MA) and the ultrafilterable [3H]-VBL was counted by liquid scintillation spectroscopy. The percent of bound drug was calculated by subtracting the free ultrafiltrable amount of [3H]-VBL from the total.
Efflux was determined after incubation of cells with 6 nM [3H]-VBL for 2 h until steady-state had been reached. The medium was aspirated, cells were washed with ice cold PBS, and 2 ml of fresh VBL-free 37°C normal medium was added back to the dishes. DPM or VPL was supplemented to this medium to study the effect of these modulators on effux. At designated time points, the fresh medium was aspirated and the cells washed with ice cold PBS. The actual time between addition of fresh medium and final aspiration was recorded in each case. Efflux was monitored from 30 s to 3 h.
Measurement of cellular A TP levels Monolayers KB-GCRI and KB-3-1 cells were pretreated for 2 h with varying concentrations of NaN3 to deplete cellular ATP levels. After washing with ice-cold PBS, the cells were scraped from the dish and transferred to a plastic test tube as a suspension of 1-10 x 106 cellsml1'. ATP levels were measured using fire fly luciferase with the Bioluminescent Somatic Cell Assay Kit [Sigma Chemical Co., St. Louis, MO; (Leach, 1986) ]. Light emission was monitored using a Monolight bioluminescent luminometer (Model 2001, Analytical Luminescence Laboratory, San Diego, CA). A standard ATP curve was run with each experiment to ensure that the concentration of ATP and resulting emission of light was in the linear range. Data were expressed as light units relative to control for each experiment.
Regression analysis of initial efflux and influx In this study, initial efflux was defined as efflux over the first 120 s of incubation in VBL-free medium. Initial influx was defined as the uptake over the first 20 s. The apparent unidirectional influx and initial efflux rate constants in KB-GRC1 and KB-3-1 cells were linear up to 240 s (r2>, 0.93).
The rate constant for initial efflux was determined by fitting a line to the efflux data over the first 120 s. Several experiments, or runs, were performed under the same combination of cell line and condition (control, VPL or DPM); the equation for the i-th run was Ci(t) = Ai [l-ket] , where Ci(t) is the concentration of VBL at any time t, Ai is the initial concentration of VBL at Cs. prior to efflux, as shown by the fitted y-intercept, and ke is the rate constant for initial efflux.
Simultaneous fitting of the data from all runs was done to obtain a single estimate of Ke; its standard error and degrees of freedom appeared in the regression output. The statistic r2 for these fittings ranged from 0.983 to 0.998 across the various combinations of cell line and condition. Similarly, for each combination of cell line and condition, the rate constant for influx was determined by fitting a line to the influx data over the first 20 s of influx. The equation for the i-th run was Ci(t) = AJ[l + ki,t], where Ci(t) is the time zero binding of VBL, as shown by the fitted y-intercept, and kin is the rate constant for initial uptake, i.e. influx. The statistic r2 for these fittings ranged from 0.930 to 0.978 across the various combinations of cell line and condition. The fitted rate constants for efflux and influx were compared across the control, VPL and DPM groups using the Satterwaite modification of Student's t test.
Statistical analysis Unless othersise noted, the data were expressed as the group mean ± SE of duplicate determinations from each of n experiments. The Student's t test for grouped data were used unless otherwise stated. In all cases, significance was at the level of P < 0.05.
Results

Effect of PGP on VBL influx
The KB-GRCI and KB-3-1 cell lines were employed because they permitted a direct comparison of the effect of PGP on VBL uptake without the confounding effects of other resistance mechanisms associated with cells selected with increasing concentrations of drug (Chabner & Fojo, 1989 However, in addition to changes in Cs. and efflux, there was a large difference in the initial influx of [3H]-VBL between the KB-GRC1 and KB-3-1 cells measured over the first few seconds of drug exposure (Figure 2 ). The initial influx data were well fit by a straight line (r2>0.930) from which the influx rate constant was calculated. As shown in Table II , the rate constant for influx was 4.2-fold lower in KB-GRC1 relative to KB-3-1 cells. A statistically significant difference in uptake existed even at 5 s after the start of the exposure (P <0.05). 
Effect of DPM on VBL influx
If the effect of PGP on initial influx was dependent on its efflux pump activity, then inhibition of the pump with pharmacologic agents such as DPM should increase initial influx. As shown in of this effect (data not shown). The ability of DPM to increase initial influx was determined by regression analysis of the data over the first 20 s of incubation. These data were well fit to a straight line (r2>0.930). Table II shows that DPM increased the rate constant for influx by 4.0 and 2.1-fold in KB-GRCl and KB-3-1 cells, respectively (P < 0.013). DPM enhanced the influx in a dose-dependent saturable manner to an equivalent level in both KB-GRCI and KB-3-1 cell lines (data not shown). Figure 4 shows that DPM inhibited the efflux [3H]-VBL in both the KB-GRCl and KB-3-1 cells with the most prominent effects observed in KB-GRCI cells. DPM produced a statistically significant decrease in both the initial efflux rate constant (Table I) initial efflux or terminal rate constants (P .0.193), but still had a significant effect on decreasing efflux by 1.9-fold (P = 0.026) as shown in Figure 4 . Consistent with its ability to both increase influx and inhibit efflux, DPM produced a large increase in the C.8 in KB-GRCI cells that plateaued at a level 9.2-fold above control at steady-state (data not shown). In comparison, DPM elevated the C,, by only 1.8-fold in KB-3-1 cells, but the enhancement was statistically significant (P <0.05, paired t test).
Further experiments were conducted to examine whether the effects of DPM were due to permeabilisation of the cellular membrane. DPM did not affect the uptake or efflux of [3H]-VBL in protein-free liposomes (data not shown) prepared as previously described (Kim et al., 1989) . In flow cytometric studies, DPM did not alter the forward light scatter of KB-3-1 cells, but the membrane permeabilising agent, digitonin (Lepers et al., 1990) , produced a maximal increase within 75 s of incubation (data not shown). Digitonin, but not DPM, also produced a large increase in permeability to propidium iodide as determined by measuring cellular fluorescence of this agent (data not shown). Furthermore, DPM did not alter the membrane potential in KB-3-1 cells as determined by measuring the accumulation of [3H]-TPP+ at 2 h (Lichtshtein et al., 1979) . These experiments provided evidence that DPM did not permeabilise cellular membranes.
As shown in Figure 2, Table II shows that VPL produced a 2.7-fold increase in the rate constant for initial influx in KB-GRCl cells but only a statistically insignificant 1.4-fold increase in KB-3-1 cells. The influx data over the first 20 s of incubation were well fit to a straight line (r2> 0.930). VPL produced a 4.6-fold increase in the C. of [3H]-VBL in KB-GRCI cells but the 1.3-fold increase in C,, in KB-3-1 cells was statistically insignificant (data not shown). As shown in Table I , VPL did not significantly inhibit initial efflux in either cell line, in agreement with a previously published report . Thus, VPL had more pronounced effects on initial influx than on initial efflux, but the greatest effect was in mdrl-overexpressing KB-GRCI cells. Thus, this inhibitor of PGP activity preferentially increased influx as compared to inhibiting efflux.
Effect of VPL on VBL influx
Effect of mutation of PGP on VBL influx
Further experiments were performed to determine the effect on VBL influx of inactivating PGP by mutating ATP binding sites. L cells were transfected with wild-type or mutationally inactivated mdrl, and an empty vector to produce the KK, MM and NEO sublines, respectively. The KK, MM and 
Effect of energy depletion on VBL influx
Since PGP is an energy-dependent pump, ATP depletion would be expected to increase influx selectively in KB-GRCI cells if PGP was responsible for the differences in influx observed between KB-GRCI and KB-3-1 cells. Therefore, cellular ATP content was depleted. Table III shows that NaN3 depleted cellular ATP levels in a dose-dependent manner. Cellular viability was > 94% after exposure to NaN3, and this treatment did not affect efficiency when the cells were subsequently seeded in normal medium (data not shown). Figure 6 shows that pretreatment for 2 h with 100 mM NaN3 increased the influx of VBL by 6.8 and 2.2-fold in KB-GRCI and KB-3-1 cells, respectively. The fact that ATP depletion equalised the influx rate indicated that the efflux pump activity of PGP was responsible for the lower rate even at times < 20s. These data supported the hypothesis that the efflux function of PGP was fully active even at the earliest time intervals and indicated that effects on the (Endicott & Ling, 1989; Juranka et al., 1989) . The product of the mdrl gene, PGP, is thought to function as an energy-dependent efflux pump, and drugs such as VPL are believed to reverse the MDR phenotype by virtue of their ability to bind to PGP and inhibit efflux activity (reviewed in Ford & Hait, 1990) . KB-GRCI and KB-3-1 cells theoretically differ from each other only by virtue of the presence of overexpressed amounts of PGP in the former cells (Choi et al., 1988) , and as anticipated, the KB-GRCl cells accumulated less VBL at steady-state, and effluxed VBL more rapidly. KB-GRC1 cells, however, also demonstrated a much lower rate of initial VBL influx than KB-3-1 cells.
During the first few seconds of VBL influx, one would expect that the cytosolic concentration of VBL would be at its lowest level relative to the levels that would be achieved over time, and thus that efflux would be relatively unimportant and incapable of influencing the rate of initial influx. However, the presence of PGP in the membrane did decrease initial influx measured over the first few seconds. Three possible explanations present themselves. The first and second possibilities are that the presence of PGP in the membrane decreases diffusional permeability to VBL, or decreases its intracellular trapping. Favouring this is the fact that PGP is known to export acids (Gros et al., 1986; Chen et al., 1987; Ames Ferro-Luzzi, 1986 ) and may serve as a chloride channel (Valverde et al., 1992) , and thus could indirectly alter the intracellular environment to decrease drug trapping. The third possibility is that PGP may be effluxing VBL directly from the cell membrane or cytoplasm under conditions which are not zero-trans.
Several lines of evidence favour the latter argument. First, when the efflux function of PGP was inhibited by DPM, an MDR modulator that binds to PGP to produce synergy with VBL (Asoh et al., 1989; Shalinsky et al., 1990b; Shalinsky et al., 1991b) , initial influx increased, and did so to a greater degree in the KB-GRC1 cells over-expressing PGP than in the KB-3-1 cells that do not express detectable amounts by Northern or polymerase chain reaction analyses of mdrl mRNA Chaudary & Roninson, 1991) . That DPM can function as an inhibitor of the efflux activity of the PGP was shown by the fact that it produced a statistically significant reduction in the initial efflux of VBL from preloaded cells. The fact that DPM inhibited efflux and did not alter membrane permeability indicates that its actions were specifically and primarily targeted to inhibiting PGP efflux activity. Like DPM, VPL also increased initial influx, and did so to a greater extent in KB-GRCI than KB-3-1 cells. Although the effect of VPL on inhibiting initial efflux did not reach the level of statistical significance, VPL has been shown to be an effective inhibitor of the efflux function of PGP in numerous other studies (Ford & Hait, 1990) . Second, when the efflux pump function of PGP was eliminated by ATP depletion, the initial influx rate increased, and the effect was larger in the cells expressing the greater amount of PGP. Third, while mouse L cells transfected with a functional form of the mdrl gene demonstrate a decrease in initial influx compared to control cells transfected with the same vector not containing the mdrl gene, cells transfected with a mutated mdrl producing a nonfunctional PGP do not have impaired initial influx. Thus, the presence of large amounts of PGP containing only a single amino acid substitution in each of the ATP binding sites was not by itself able to alter initial influx, arguing that simply the presence of the protein in the membrane did not change diffusional permeability to VBL.
While these kinetic studies could not distinguish between efflux from the membranal or cytoplasmic compartments, we believe that the data are most consistent with the hypothesis that PGP can export substrates directly from the cellular membrane. In support of this concept is the rapidity with which efflux activity was observed and inhibited, and the fact that most substrates and modulators of PGP activity are lipophilic (Ford & Hait, 1990 ) and thus would be expected to interact more highly within the lipid membrane bilayer. Furthermore, reports in the literature indicate that PGP serves as a hydrophobic membrane 'vacuum cleaner' to export drug from the cellular membrane (Gros et al., 1986; Raviv et al., 1990; Gottesman & Pastan, 1990) . A more prominent role for the membranal rather than cytoplasmically-bound substrate is invoked by the work of Raviv et al. (1990) who have reported that doxorubicin interacts with a site on PGP within the cellular membrane. In addition, identification of putative binding sites close to or within the transmembrane regions of PGP would also support this hypothesis (Choi et al., 1988; Greenberger et al., 1991; Gros et al., 1991; Hait & Aftab, 1992) .
If PGP can utilise VBL in the membrane compartment as a substrate, then what appears to be a reduction in initial influx is in fact due to the ability of the pump to rapidly efflux VBL. Other investigators have also demonstrated the ability of PGP to efflux VBL and doxorubicin within millisec to sec of exposure in MDR cells (Cano-Gauci et al., 1990) , and modulators of the MDR phenotype have been shown to inhibit PGP-chloride-associated channel activity within 30 s of exposure (Valverde et al., 1992) providing further support for the concept than that PGP can efflux drug even after very short periods of drug exposure, and that modulators can act rapidly enough to account for their ability to increase initial uptake within a few seconds of addition to the culture.
In summary, this report demonstrates that the KB-GRC1 cell line presents a good model for the study of PGP function at short time intervals. Specifically, PGP-mediated efflux can be quantitated at short time points as can the efflux-modulating activity of MDR chemosensitisers such as DPM and VPL. These data are consistent with the hypothesis that PGP directly effluxes drug from the cellular membrane.
